Trial Profile
Impact of Fiasp on Glycaemic Control in a Real World Population With Type 1 Diabetes Mellitus Using Flash Glucose Monitoring
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Nov 2020
Price :
$35
*
At a glance
- Drugs Insulin aspart (Primary)
- Indications Type 1 diabetes mellitus
- Focus Therapeutic Use
- Acronyms GoBolus
- Sponsors Novo Nordisk
- 25 Sep 2020 Results (n=243) presented at the 56th Annual Meeting of the European Association for the Study of Diabetes
- 16 Jun 2020 Results (n=243) presented at the 80th Annual Scientific Sessions of the American Diabetes Association.
- 14 Oct 2019 Status changed from active, no longer recruiting to completed.